Arbutus Biopharma Corp
ABUSNasdaqCIK 1447028HealthcareFiscal year ends Dec 31
Reports and events: 561 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2017-10-0310:32 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-060416 |
| 2017-10-0308:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-005871 |
| 2017-09-2510:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-005701 |
| 2017-09-2508:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-005694 |
| 2017-09-2217:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-005685 |
| 2017-09-2012:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-005617 |
| 2017-09-1520:58 ET | SC 13D | Ownership report, active investor | 0001193125-17-285465 |
| 2017-09-0711:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-005435 |
| 2017-08-1413:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-005024 |
| 2017-08-0317:28 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001628280-17-008044 |
| 2017-08-0316:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-17-004691 |
| 2017-08-0116:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-004545 |
| 2017-07-2710:46 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001171843-17-004383 |
| 2017-07-0617:49 ET | SC 13D/A | Ownership report, active investor, amended | 0000903423-17-000447 |
| 2017-06-1417:29 ET | SC 13D/A | Ownership report, active investor, amended | 0000903423-17-000417 |
| 2017-06-0211:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-003427 |
| 2017-05-2613:36 ET | 8-K | 5.07 Shareholder vote results | 0000912282-17-000133 |
| 2017-05-2207:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-003229 |
| 2017-05-1716:56 ET | 10-K/A | Annual report, amendedPeriod 2017-03-31 | 0001628280-17-005644 |
| 2017-05-0417:23 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001628280-17-004968 |
| 2017-05-0416:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-17-002663 |
| 2017-05-0208:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-002480 |
| 2017-04-2516:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-002303 |
| 2017-04-1817:00 ET | DEF 14A | Proxy statementPeriod 2017-04-18 | 0001628280-17-003789 |
| 2017-04-1308:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-17-002101 |
| 2017-03-2819:52 ET | 8-K | 8.01 Other events | 0001628280-17-002951 |
| 2017-03-2420:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-17-002872 |
| 2017-03-2206:06 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001628280-17-002760 |
| 2017-03-2107:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-17-001641 |
| 2017-03-2015:00 ET | 8-K/A | 1.01 Entry into a material agreement | 0001628280-17-002711 |
| 2017-03-1617:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-001586 |
| 2017-03-0609:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-001299 |
| 2017-02-0916:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-000795 |
| 2017-02-0806:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-17-000735 |
| 2016-12-2214:05 ET | 10-Q/A | Quarterly report, amendedPeriod 2016-09-30 | 0000912282-16-000926 |
| 2016-12-1216:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-013604 |
| 2016-11-1416:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-013217 |
| 2016-11-0316:49 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001628280-16-020766 |
| 2016-11-0316:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-16-012925 |
| 2016-10-1916:26 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-16-150928 |
| 2016-10-1916:13 ET | SC 13D | Ownership report, active investor | 0001104659-16-150919 |
| 2016-10-0610:22 ET | 8-K | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors | 0000912282-16-000855 |
| 2016-10-0312:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-012347 |
| 2016-10-0307:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-012337 |
| 2016-09-2916:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-012315 |
| 2016-09-2813:53 ET | 8-K | 3.01 Delisting notice | 0000912282-16-000848 |
| 2016-09-1307:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-012137 |
| 2016-08-1914:23 ET | 8-K | 1.01 Entry into a material agreement | 0000912282-16-000805 |
| 2016-08-1008:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-011661 |
| 2016-08-0816:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-16-011587 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.